IDO1 and neoplasm: When SPNpros were delivered to tumor tissues, the peptides were specifically cleaved by tumor-overexpressed cathepsin B to release free IDO-degrading PROTACs and the free PROTACs mediated IDO degradation utilizing the VHL E3 ligase-UPS pathway.